The demand for weight-loss drug Wegovy is becoming more popular, as sales continue to increase.
In an interview with CNN, Novo Nordisk Chief Executive Officer Lars Fruergaard Jorgensen said at least 25,000 people are starting the medicine weekly in the U.S.
Wegovy received FDA approval in 2021 for chronic weight management. The company also makes Ozempic.
The George Washington University has experts available to offer insight and information as to what we know about the drug. If you would like to schedule an interview, please contact Katelyn Deckelbaum, [email protected].
William Dietz is the director of the Sumner M. Redstone Global Center for Prevention and Wellness at the GW Milken Institute School of Public Health. He can talk in detail about the drug and the success rate with weight loss.
Marijane Hynes is a clinical professor of medicine at GW School of Medicine and Health Sciences. She started the Weight Loss Clinic, which focuses on behavior changes and diabetes prevention and is committed to helping her patients lose weight as a treatment for many of their medical problems.
-GW-